Clinical Trials Search Results
Quick Links
Dictionary
Funding Opportunities
NCI Publications
NCI Calendar
Español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer
Temozolomide Plus Radiation Helps Brain Cancer
Confirmed: Raloxifene Drops Risk of Breast Cancer
Bortezomib Delays Progression of Multiple Myeloma
Annual Report to the Nation
Past Highlights
Results:
1-10 of 229
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/2002
First Published:
1/1/1996
1.
Phase III Randomized Study of Vaginal Hysterectomy and Bilateral Salpingo-Oophorectomy (BSO) Via Laparoscopy Versus Total Abdominal Hysterectomy and BSO Via Conventional Laparotomy Plus Pelvic and Para-Aortic Lymph Node Sampling in Patients With Stage I or IIA, Grade I-III Endometrial Cancer or Uterine Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
GOG-LAP2
Last Modified:
6/8/2004
First Published:
8/1/1998
2.
Phase III Study of Intraoperative Lymphatic Mapping in Patients With Invasive Squamous Cell Carcinoma of the Vulva
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic, Treatment
Active
Any age
NCI
GOG-173
Last Modified:
7/9/2004
First Published:
2/1/1999
3.
Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Not specified
NCI
GOG-174
ECOG-G174
Last Modified:
6/3/2004
First Published:
4/1/2000
4.
Phase III Randomized Study of Oral Thalidomide Versus Placebo in Patients With Androgen-Dependent Nonmetastatic Prostate Cancer After Limited Hormonal Ablation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
NCI-00-C-0080
NCI-T99-0053
Last Modified:
3/26/2003
First Published:
5/1/2000
5.
Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
25 and under at diagnosis
NCI
NCI-00-C-0092F
AMGEN-20000124
Last Modified:
6/8/2004
First Published:
1/1/2002
6.
Phase III Randomized Study of Fibrin Sealant to Reduce Lymphedema Incidence After Lymph Node Dissection in Patients With Vulvar Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
Over 18
NCI
GOG-0195
NCI-P01-0201
Last Modified:
6/7/2004
First Published:
7/1/2002
7.
Phase III Randomized Study of Tamoxifen Versus Thalidomide in Patients With Only a Biochemical Recurrence of Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer After First-Line Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Not specified
NCI
GOG-0198
Last Modified:
4/7/2004
First Published:
2/21/2003
8.
Phase III Randomized Study of Operative Debulking and Systemic Chemotherapy With or Without Intra- and Peri-Operative Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Low-Grade Gastrointestinal Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
NCI-03-C-0085
Last Modified:
6/8/2004
First Published:
3/24/2003
9.
Phase III Randomized Study of Amifostine Versus No Treatment For Platinum-Induced Peripheral Neuropathy in Patients With Gynecologic Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
NCI
GOG-0192
Last Modified:
6/8/2004
First Published:
6/23/2003
10.
Phase III Randomized Study of Paclitaxel and Cisplatin Versus Vinorelbine and Cisplatin Versus Gemcitabine and Cisplatin Versus Topotecan and Cisplatin in Patients With Stage IVB, Recurrent, or Persistent Carcinoma of the Cervix
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
GOG-0204
Select All on One Page
1
2
3
4
Next >
Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Site Help
|
Site Map
A Service of the National Cancer Institute